42
Percutaneous nephrostomy insertion for patients with bilateral ureteric obstruction caused by prostate cancer

2006 ◽  
Vol 97 ◽  
pp. 12-12
Author(s):  
D.G. MURPHY ◽  
M.J. SWINN
Keyword(s):  
Prostate Cancer ◽  
Percutaneous Nephrostomy ◽  
Ureteric Obstruction

PERCUTANEOUS NEPHROSTOMY INSERTION FOR PATIENTS WITH URETERIC OBSTRUCTION CAUSED BY PROSTATE CANCER

2006 ◽  
Vol 5 (2) ◽  
pp. 205
Author(s):  
J. Nariculam ◽  
D. Murphy ◽  
N. Sellars ◽  
S. Gwyther ◽  
M. Swinn
Keyword(s):  
Prostate Cancer ◽  
Percutaneous Nephrostomy ◽  
Ureteric Obstruction

Transient ureteric obstruction following pelvic floor reconstruction

2021 ◽  
Vol 14 (5) ◽  
pp. e238669
Author(s):  
Liam Joseph Beamer ◽  
Sarah Neary ◽  
Thomas McCormack ◽  
David Ankers
Keyword(s):  
Pelvic Floor ◽  
Kidney Injury ◽  
Solitary Kidney ◽  
Percutaneous Nephrostomy ◽  
Pelvic Organ ◽  
Ureteric Obstruction ◽  
Pelvic Floor Reconstruction ◽  
Transient Nature ◽  
Recurrent Pelvic Organ Prolapse ◽  
History Of

We describe the first reported case of transient distal ureteric obstruction attributed to post-surgical oedema in a patient with a solitary kidney. This occurred following combined pelvic floor repair and sacrospinous fixation for recurrent pelvic organ prolapse and manifested clinically as anuria, radiological hydroureter and acute kidney injury in the postoperative period. The transient nature of this obstruction, which was managed by a temporary percutaneous nephrostomy, indicates that it was caused by ureteric compression secondary to soft tissue oedema following surgery. We highlight the importance of this potential complication in females with a history of nephrectomy, unilateral renal tract anomalies or severely diminished renal reserve.

The baby pacifier sign: Bilateral ureteric obstruction secondary to prostate cancer

2020 ◽  
pp. 205141582092781
Author(s):  
Antoine Kass-Iliyya ◽  
Aloysius Okeke ◽  
Maurice Gibson
Keyword(s):  
Prostate Cancer ◽  
Ureteric Obstruction

scholarly journals Ureteral Stent and Percutaneous Nephrostomy in Managing Malignant Ureteric Obstruction of Gastrointestinal Origin: A 10 Years’ Experience

2020 ◽  
Vol 2 (4) ◽  
pp. 456-468
Author(s):  
Elisa De Lorenzis ◽  
Elena Lievore ◽  
Matteo Turetti ◽  
Andrea Gallioli ◽  
Barbara Galassi ◽  
...  
Keyword(s):  
Cancer Diagnosis ◽  
Poor Prognosis ◽  
Descriptive Analysis ◽  
Percutaneous Nephrostomy ◽  
Ureteral Stent ◽  
Ureteric Obstruction ◽  
Upper Gi ◽  
Variate Analysis ◽  
Malignant Ureteral Obstruction ◽  
Analysis Survival

Background: Malignant ureteral obstruction (MUO) is variable in presentation and there is no consensus on its management, especially when caused by gastrointestinal (GI) malignancies. Our aim was to describe our experience with this oncological complication. Methods: We retrospectively analyzed the outcomes of ureteral stent and nephrostomy tube (NT) positioning for GI-related MUO from 2010 to 2020. We performed descriptive analysis, survival analysis, and uni- and multi-variate analysis. Results: We included 51 patients. NT was mainly used when bladder involvement occurred and when MUO revealed an ex novo cancer diagnosis. Survival was poorer in patients with new diagnoses and in those receiving no treatment after decompression. Moreover, MUO caused by upper-GI tumors was related to shorter overall survival. Conclusions: GI tumors causing MUO should be considered of poor prognosis. Treatment decisions should be weighted accurately by both specialists and the patient.

scholarly journals Ureteric obstruction secondary to unusual metastasis of prostate cancer

2020 ◽  
Vol 31 ◽  
pp. 101182
Author(s):  
Alexandar Blazevski ◽  
Amer Amin ◽  
Gordon O'Neill
Keyword(s):  
Prostate Cancer ◽  
Ureteric Obstruction

scholarly journals Urological Management of Extramural Malignant Ureteric Obstruction: A Survey of Irish Urologists

2017 ◽  
Vol 11 (1) ◽  
pp. 21-25 ◽  
Author(s):  
Eabhann M. O'Connor ◽  
Gregory J. Nason ◽  
Eamon A. Kiely
Keyword(s):  
Online Survey ◽  
Response Rate ◽  
Percutaneous Nephrostomy ◽  
Equal Proportion ◽  
Metallic Stent ◽  
Ureteric Obstruction ◽  
Management Options ◽  
Survey Tool ◽  
The Republic ◽  
Primary Service

Introduction: The absence of guidelines in the management of extramural malignant ureteric obstruction leads to confusion in decision making and in the interaction between urology and other clinical disciplines. In this study, we surveyed consultant urologists with the goal of achieving a better consensus on optimal management options. Methods: A multiple choice survey was sent via the online survey tool “SurveyMonkey” to all consultant urologists practicing in the Republic of Ireland. Results: There was a response rate of 57.5% (n = 23). Twenty-two (96%) consultants consider the use of percutaneous nephrostomy with placement of antegrade ureteric stent but only 22% (n = 5) would consider using a metallic stent. Eleven (48%) respondents favor retrograde stenting in the first instance with an equal proportion choosing an antegrade method. Nine (39%) consultants perform the initial stent change at 4-6 months, 8 (35%) at 2-4 months, and 1 at < 2 months and 6-10 months respectively. Total 59% (n = 13) of respondents felt that the duration of expected patient survival influenced their decision and agreement to stent with 42% (n = 8) saying this survival would need to be > 6 months and 82% (n = 18) were generally happy with the level of ongoing communication between urology and the primary service managing the patient. Conclusion: There is a lack of consensus regarding the management of this challenging problem, particularly with regard to timing of first stent change and whether to initially use an antegrade or retrograde approach. This reflects the heterogeneous patient cohort and the important factors of life expectancy and patient co-morbidities.

Sign in / Sign up

Export Citation Format

Share Document